Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume h

Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume h

Item

http://www.wikidata.org/entity/Q36010000

Q36010000

about

Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer.Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review.Dose-volume analysis of predictors for chronic gastrointestinal complications in patients with cervical cancer treated with postoperative concurrent chemotherapy and whole-pelvic radiation therapy.Association between dose-volume parameters and acute bone marrow suppression in rectal cancer patients treated with concurrent chemoradiotherapy.

P2860

Q33442782-371EAF94-ECF1-4EFB-9EA8-F793B31FCED5 Q37301081-EDC39983-EF21-4C9D-8E92-366A4A342EE1 Q37364032-2C80BA78-AD7E-4441-B416-FA8C4FC0104A Q39132126-47505CCA-C5D4-4D8F-BA12-91C863410438 Q42358784-9734A8FE-E9A3-4B8D-BCF4-382AD275685A Q46775347-F8E4FC63-17FD-41CE-8B39-CAF136143951

P2860

Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume h

Item

http://www.wikidata.org/entity/Q36010000

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intensity-modulated radiation ...... mplications, and dose-volume h

@ast

Intensity-modulated radiation ...... mplications, and dose-volume h

@en

type

Item

label

Intensity-modulated radiation ...... mplications, and dose-volume h

@ast

Intensity-modulated radiation ...... mplications, and dose-volume h

@en

prefLabel

Intensity-modulated radiation ...... mplications, and dose-volume h

@ast

Intensity-modulated radiation ...... mplications, and dose-volume h

@en

P1476

Intensity-modulated radiation ...... mplications, and dose-volume h

@en

P2093

Hikari Unno

http://www.w3.org/2001/XMLSchema#string

Iori Sumida

http://www.w3.org/2001/XMLSchema#string

Katsumi Kozasa

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Ogawa

http://www.w3.org/2001/XMLSchema#string

Keisuke Tamari

http://www.w3.org/2001/XMLSchema#string

Michiko Yamashita

http://www.w3.org/2001/XMLSchema#string

Osamu Suzuki

http://www.w3.org/2001/XMLSchema#string

Seiji Mabuchi

http://www.w3.org/2001/XMLSchema#string

Tadashi Kimura

http://www.w3.org/2001/XMLSchema#string

Yasuo Yoshioka

http://www.w3.org/2001/XMLSchema#string

P2860

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.

Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy.

Radiation dose-volume effects in the stomach and small bowel.

Nedaplatin: a radiosensitizing agent for patients with cervical cancer.

Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.

A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.

Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.

Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.

P2888

s13014-015-0486-5

P304

180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-015-0486-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fumiaki Isohashi

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281261305

http://www.w3.org/2001/XMLSchema#string

P6179

1034496193

http://www.w3.org/2001/XMLSchema#string

P698

26300325

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

hysterectomy

P932

4554318

http://www.w3.org/2001/XMLSchema#string

Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume h

about

P2860

P2860

Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume h

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P921

P932